Sponsor

Centre National de la Recherche Scientifique, France

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Centre National de la Recherche Scientifique, France appears in 19 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials19
Recruiting shown3
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

19 shown
Dysarthria in Parkinson's Disease: Lusophony vs. Francophony ComparisonNCT02753192 · lead sponsor · 2014-01-01
UNKNOWN
Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral ProteinNCT06441123 · collaborator · 2025-02-10
RECRUITING
Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-ADNCT06582199 · collaborator · 2024-10-31
RECRUITING
Insulin Resistance in Multiple System AtrophyNCT04250493 · collaborator · 2020-10-28
RECRUITING
Working Memory Functioning in Alzheimer's Disease and Vascular DementiaNCT06321380 · collaborator · 2024-04-01
UNKNOWN
Efficacy of a Cognitive - Affective - Addictive Based Intervention to Decrease Food Craving in Obese Patients.NCT04338178 · collaborator · 2021-11-15
TERMINATED
PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF StudyNCT04189029 · collaborator · 2019-12-09
UNKNOWN
Effect of the Inhibitors of the Way JAK-STAT on Regulatory B CellsNCT03755297 · collaborator · 2019-02-12
TERMINATED
The Role of the Thymus in Type I Diabetes.NCT03236558 · collaborator · 2018-03-01
WITHDRAWN
Inflammasome Activation Via Circulating MetabolitesNCT03191175 · collaborator · 2017-07-03
COMPLETED
Explorations of the Normal Neural Behavioral and Pathological Bases of MetacognitionNCT03140475 · collaborator · 2017-04-27
COMPLETED
Incretin-mimetic Hypoglycemic Drugs and Severe RetinopathyNCT02671864 · collaborator · 2016-04-11
UNKNOWN
Pathological and Non-pathological Aging, Physical Activity, Genotype and CognitionNCT02520232 · collaborator · 2015-06-01
COMPLETED
Hand-held Gamma Camera in the SNOLL ProcedureNCT02101320 · collaborator · 2015-05-20
COMPLETED
Respiratory Quotient and Food Liking, Food Wanting and Food ConsumptionNCT01122082 · collaborator · 2008-10-01
COMPLETED
Obesity, Physical Inactivity or Dietary Fat ?NCT00434265 · collaborator · 2007-03-01
COMPLETED
Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) StudyNCT00350935 · collaborator · 2006-09-01
COMPLETED
Evaluation of Two New Medical Instruments Dedicated to the Sentinel Lymph Node Technique in Case of Breast CancerNCT00357487 · collaborator · 2006-06-01
COMPLETED
Measuring Time Windows in Patients With Schizophrenia and Healthy ControlsNCT00350805 · collaborator · 2005-09-01
COMPLETED

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Centre National de la Recherche Scientifique, France as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

collaborator18
lead sponsor1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.